Company News

Nanalysis Scientific Corp. (Nanalysis, TSXV: NSCI OTCQX: NSCIF FRA: 1N1 ), released today its fourth quarter and annual 2020 results.

Nanalysis Scientific Corp. Logo (CNW Group/Nanalysis Scientific Corp.)


Three months ended December 31

Twelve months ended December 31

($000's)

2020

2019

($) Change

2020

2019

($) Change








Revenue

2,680

2,123

557

7,874

8,364

(490)

Cost of products sold

930

430

500

2,707

2,304

403

Gross profit (1)

1,750

1,693

57

5,167

6,060

(893)








Expenses







Sales and marketing

979

865

114

3,131

2,453

678

General and adminstration

1,030

411

619

3,204

2,562

642

Research and development

437

-

437

476

-

476

Earnings (loss) before other items

(696)

417

(1,113)

(1,644)

1,045

(2,689)








Other items (1)

568

101

467

2331

2444

-113

Deferred tax expense (recovery)

(39)

297

(336)

(297)

261

(558)

Net earnings (loss)

(1,225)

19

(1,244)

(3,678)

(1,660)

(2,018)

Other comprehensive income

33

-

33

215

-

215

Total comprehensive income (loss)

(1,192)

19

(1,211)

(3,463)

(1,660)

(1,803)


(1) other items includes business acquisition transaction costs, stock-based compensation, depreciation and amortization expense, finance expense (income), foreign exchange loss, and RS2D earn out

OVERALL PERFORMANCE
For the three months ended December 31, 2020 , the Company reported consolidated revenue of $2,680K , an increase of $557K or 26% from the comparative period in 2019. The Company continued to be impacted by COVID-19. Travel restrictions have delayed the completion of several key contracts, but despite these challenges overall revenue increased in the fourth quarter of 2020 compared to the fourth quarter of 2019. The increase in revenue is due to the inclusion of RS2D revenue, which was acquired in March 2020 , as well as the first four shipments of Nanalysis' new flagship product: The 100MHz spectrometer. As at December 31, 2020 Nanalysis has $3.9 million of backlog of orders associated with the 100MHz product, of which $1.5 million has been prepaid by customers and is recorded in unearned revenue on the balance sheet.

Gross profit for three months ended December 31, 2020 , was $1,750K (a margin of 65%) compared to gross profit of $1,693K (a margin of 79%) for the fourth quarter of 2019. The three months ended December 2019 had a cost recovery in cost of goods sold, resulting in increased margins for 2019.

The Company's comprehensive loss for the three months ended December 31, 2020 , was $1,192K as compared to comprehensive income of $19K for the comparable period of 2019. The comprehensive loss for the three months ended December 31, 2020 , was due to increased depreciation and amortization, increased stock-based compensation expense, increased research and development expenses, an RS2D earn-out payment, and increased operating expenses from RS2D, that were not in existence in the comparative period. These have been partially offset by increased finance income, a deferred tax recovery, increased other comprehensive income, and increased revenue.

For the twelve months ended December 31, 2020 , the company reported consolidated revenue of $7,874K , a decrease of 6% from the $8,364K recognized for the twelve months ended December 31, 2019 . The Company's comprehensive loss for the twelve months ended December 31, 2020 was $3,463K as compared to comprehensive loss of $1,660K in the comparable period of 2019. The decrease in revenue and increased comprehensive loss was due to the impact of COVID-19 which also caused delays in the development of the 100MHz product and the completion of several significant contracts in the year.

FINANCIAL POSITION
At December 31, 2020 , Nanalysis had $3,049K ( December 31, 2019 - $8,534K ) of working capital, including $3,158K ( December 31, 2019 - $6,619K ) in cash. The Company has an undrawn line of credit of $2,000K and $785K of available borrowing on the Western Economic Diversification Canada interest free loan. Nanalysis's business has been affected by COVID-19 and as such is eligible for a subsidy of 75% of employees' wages in Canada . During the twelve months ended December 31, 2020 , the Company claimed $1,449K and to date has received $1,280K from the Canadian emergency wage subsidy ("CEWS"). Subsequent to the end of 2020 the Company received:

  • $1.0 million , under the Regional Recovery Relief Fund, the loan bears interest at three percent above the Bank of Canada rate and is repayable in 35 consecutive monthly installments of $28K commencing January 1, 2023 .
  • On December 18, 2020 Nanalysis executed an original equipment manufacturing contract ("OEM") with a European Corporation. Per the agreement an initial licensing fee of $876K was due within 15 days of signing and was received on January 11, 2021 .
  • On December 10, 2020 RS2D won a $1.2 million non-repayable grant to further leverage its proprietary Magnetic Resonance Imaging (MRI) technology for smart NextGen clinical MRI systems. Pursuant to the grant and subsequent to year end RS2D received an initial payment on March 29, 2021 of $629K .
  • On April 9, 2020 , RS2D received $383K for their 2019 Credit impot Recherche.

Nanalysis will continue to monitor revenues and seek government support for both Canadian and French operations where assistance is offered.

OUTLOOK
Nanalysis's business has been affected by Covid-19 restrictions as our sales cycle has typically involved face-to-face customer meetings and marketing in person and at trade shows. While we have been exceedingly proud of developing the world's first 100 MHz (2.35 Tesla) spectrometer and the accompanying customer demand for this product, the Company has experienced a delayed timeline for completing QA/QC to meet manufacturing standards and procedures. Pandemic-related restrictions on travel have also slowed our development partnerships with Bosch, Sartec, and others. Despite these restrictions, we have been able to integrate RS2D's MR electronics and technologies into our existing products. The RS2D unit has performed well in its initial 10 months under Nanalysis's ownership. We are optimistic that, as Covid-19 restrictions ease in the latter half of 2021, Nanalysis is well-positioned to capitalize on our current initiatives and continue to drive expansion opportunities. As always, we will do so while striving to deliver value to our shareholders.

About Nanalysis Scientific Corp. ( TSXV: NSCI , OTCQX: NSCIF, FRA:1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol ' NSCI ' ,Over the Counter (OTC) in the United States under the ticker symbol ' NSCIF ', and on the Frankfurt Exchange (FRA) under the symbol ' 1N1 '.

Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).

Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its cutting edge 60 and 100 MHz spectrometers require no liquid helium or other cryogens. Its spectrometers are used by chemical professionals spanning industries, including, but not limited to, oil and gas, chemical mining, pharmaceutical, and biotechnology.

Through its European subsidiary RS2D, the Company offers electronic boards and software used to drive MRI equipment in pre-clinical configurations and are being incorporated into next-gen MRI systems.

To sign up for updates relating to Nanalysis, please complete the online form found HERE .

Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE Nanalysis Scientific Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2021/22/c3358.html

News Provided by Canada Newswire via QuoteMedia

Elisabeth Preston to Retire from KWESST Board and Step Down as Corporate Secretary; Expected U.S. Replacement for Board Seat Pending

Elisabeth Preston to Retire from KWESST Board and Step Down as Corporate Secretary; Expected U.S. Replacement for Board Seat Pending

KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (FSE: 62U) ("KWESST" or "the Company"), a developer of next-generation tactical systems for military, security, and personal defense markets, today announced that Elisabeth Preston will be retiring as director and Corporate Secretary effective immediately.

Ms. Preston joined the KWESST board February 21st, 2021 and has also served since then as Corporate Secretary. Her exit is precipitated by an urgent necessity for Ms. Preston to focus her attention on her full time occupation as Chief Legal Counsel and Vice President International Compliance with a top global defense contractor with significant operations in Europe.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Applied UV Adds Veteran Leader and Business Executive Monica Woo to Board of Directors

Applied UV Adds Veteran Leader and Business Executive Monica Woo to Board of Directors

Former President 1-800 FLOWERS

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that Monica Woo has joined the Board of Directors. Monica Woo joins Applied UV's extensive Executive leadership team and Board as the Company continues the global market expansion of its patented, disruptive and highly effective suite of fixed and mobile air purification solutions (Airocide and Scientific Air).

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
dynaCERT Adds Simply Green's Expertise in the Oil & Gas Industry

dynaCERT Adds Simply Green's Expertise in the Oil & Gas Industry

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") is pleased to announce that dynaCERT 's strategic dealer in the Canadian Oil & Gas market, Simply Green Distributors Inc. ("Simply Green" or "SGD"), a successful distributor of green technology, based in Red Deer, Alberta, Canada, is offering the immediate availability of dynaCERT's HydraGEN™ products based on dynaCERT's patented and proprietary Technology offering a global solution to reduce pollution.

SGD is distributing the Company's new line of products using hydrogen technology designed to make contributions to lowering GHG emissions and designed to show important savings in fuel consumption in the Oil & Gas, Construction and Transportation industries. The hydrogen units, which are added as an aftermarket product to existing equipment or machinery, delivers hydrogen-on-demand. With the use of distilled water, the units are up and running immediately after installation.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Applied UV to Host First Quarter 2022 Conference Call on May 24, 2022

Applied UV to Host First Quarter 2022 Conference Call on May 24, 2022

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, May 24, 2022 at 9:00 am ET to review its financial results. First quarter 2022 financial results will be released after market close on Monday, May 23 rd and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI .

Conference Call/Webcast Information

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
DGTL Holdings Inc. Reports New Campaign Extension for Nasdaq Listed E-Sports Gaming Client

DGTL Holdings Inc. Reports New Campaign Extension for Nasdaq Listed E-Sports Gaming Client

Campaign Extension to Build Awareness of New Online Sports Betting Regulations, Now Live Across the Province of Ontario, Canada

DGTL Holdings Inc. (TSXV: DGTL) ("DGTL" or the "Company") is pleased to announce that its wholly owned subsidiary Hashoff LLC has launched a new social media content marketing campaign with a Nasdaq listed e-sports gaming client. The campaign is focused on promoting brand awareness and new user registration on its client's software platform now that allows online sports betting across the Province of Ontario, Canada.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Applied UV Announces Inclusion in a Multi-Million Dollar Contract Offering Throughout Non-Public Schools in The State of Washington

Applied UV Announces Inclusion in a Multi-Million Dollar Contract Offering Throughout Non-Public Schools in The State of Washington

Contract Is Part of the US Govt $3.5B National EANS II Program Designed to Provide Funding For Air Purification and Other Supplies For Non-Public Schools

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announces that its wholly owned subsidiary Sterilumen has been notified that its US Dealer, DA International, has been included in a multi-million dollar contract which will include in its offering, the Company's suite of Airocide™ air purification solutions and other related disinfection supplies to non-public schools throughout the State of Washington.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×